Immunogenicity and reactogenicity of a reduced antigen content diphtheria, tetanus and acellular pertussis vaccine dTpa) in 10 to 11 years old children and in adults
K Abarca, F Valdivieso, M Potin, I Ibáñez… - Revista Medica de …, 2002 - europepmc.org
[Immunogenicity and reactogenicity of a reduced antigen content diphtheria, tetanus and
acellular pertussis vaccine dTpa) in 10 to 11 years old children and in adults]. - Abstract - Europe …
acellular pertussis vaccine dTpa) in 10 to 11 years old children and in adults]. - Abstract - Europe …
Safety and immunogenicity of SIIPL Tdap, a new tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, in healthy subjects 4–65 years of age: A …
I Aydin, M May, F Pisano, N Mpofu-Maetzig, L Grode… - Vaccine, 2023 - Elsevier
Background This study assessed the safety and immunogenicity of a new booster vaccine
against tetanus, diphtheria, and pertussis manufactured by Serum Institute of India Pvt. Ltd …
against tetanus, diphtheria, and pertussis manufactured by Serum Institute of India Pvt. Ltd …
Immunogenicity of a single dose of reduced-antigen acellular pertussis vaccine in a non-vaccinated adolescent population
M Knuf, F Zepp, C Meyer, E Grzegowski, J Wolter… - Vaccine, 2006 - Elsevier
German adolescents (n= 123) without previous pertussis vaccination, no history of pertussis
and low IgG-anti-pertussis-toxin (PT) levels received one dose of the Tdap vaccine …
and low IgG-anti-pertussis-toxin (PT) levels received one dose of the Tdap vaccine …
Booster vaccination of toddlers with reduced antigen content diphtheria–tetanus–acellular pertussis vaccine
Immunogenicity and reactogenicity of DTPa and reduced antigen dTpa booster vaccines
were compared to a hepatitis A control vaccine in DTPa-primed toddlers aged 18–20 …
were compared to a hepatitis A control vaccine in DTPa-primed toddlers aged 18–20 …
Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model
HJ Kwon, SB Han, BR Kim, KR Kang, DH Huh… - BMC infectious …, 2017 - Springer
Background Tetanus-reduced dose diphtheria-acellular pertussis (Tdap) vaccination during
adolescence was introduced in response to the resurgence of pertussis in various countries …
adolescence was introduced in response to the resurgence of pertussis in various countries …
Reduced-Antigen, Combined Diphtheria, Tetanus and Acellular Pertussis Vaccine, Adsorbed (Boostrix®) A Review of its Properties and Use as a Single-Dose Booster …
PL McCormack - Drugs, 2012 - Springer
Reduced-antigen, combined diphtheria, tetanus and three-component acellular pertussis
vaccine (Tdap; Boostrix®) is indicated for booster vaccination against diphtheria, tetanus …
vaccine (Tdap; Boostrix®) is indicated for booster vaccination against diphtheria, tetanus …
[HTML][HTML] Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular …
V Pool, A Tomovici, DR Johnson, DP Greenberg… - Vaccine, 2018 - Elsevier
Background In a prospective, randomized pivotal phase III clinical trial, the immunogenicity
and reactogenicity of a tetanus-diphtheria-acellular pertussis vaccine (Tdap) and a tetanus …
and reactogenicity of a tetanus-diphtheria-acellular pertussis vaccine (Tdap) and a tetanus …
A randomized trial of two acellular pertussis vaccines (dTpa and pa) and a licensed diphtheria-tetanus vaccine (Td) in adults
FM Turnbull, TC Heath, BB Jalaludin, MA Burgess… - Vaccine, 2000 - Elsevier
A single blinded randomized controlled trial to compare the reactogenicity and
immunogenicity of adult formulated dTpa and monovalent pa vaccines with a licensed Td …
immunogenicity of adult formulated dTpa and monovalent pa vaccines with a licensed Td …
Immunogenicity of a new enhanced tetanus-reduced dose diphtheria-acellular pertussis (Tdap) vaccine against Bordetella pertussis in a murine model
KR Kang, DH Huh, JA Kim, JH Kang - BMC immunology, 2021 - Springer
Background The necessity of the tetanus-reduced dose diphtheria-acellular pertussis (Tdap)
vaccine in adolescence and adults has been emphasized since the resurgence of small …
vaccine in adolescence and adults has been emphasized since the resurgence of small …
Immunogenicity and reactogenicity of acellular pertussis booster vaccines in children: standard pediatric versus a reduced-antigen content formulation
CU Meyer, P Habermehl, M Knuf, B Hoet… - Human …, 2008 - Taylor & Francis
Booster vaccination with a reduced-antigen-content dTpa, pediatric DTPa or adult Td
vaccine in DTPa-primed children aged 4-6 years was evaluated. Immunogenicity and CMI …
vaccine in DTPa-primed children aged 4-6 years was evaluated. Immunogenicity and CMI …